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Impact of central and peripheral TRPV1 and ROS
levels on proinflammatory mediators and
nociceptive behavior
Karin N Westlund1*, Mikhail Y Kochukov2, Ying Lu2, Terry A McNearney2,3,4
Abstract
Background: Transient receptor potential vanilloid 1 (TRPV1) channels are important membrane sensors on
peripheral nerve endings and on supportive non-neuronal synoviocytes in the knee joint. TRPV 1 ion channels
respond with activation of calcium and sodium fluxes to pH, thermal, chemical, osmotic, mechanical and other
stimuli abundant in inflamed joints. In the present study, the kaolin/carrageenan (k/c) induced knee joint arthritis
model in rats, as well as primary and clonal human synoviocyte cultures were used to understand the reciprocal
interactions between reactive nitroxidative species (ROS) and functional TRPV1 channels. ROS generation was
monitored with ROS sensitive dyes using live cell imaging in vitro and in spinal tissue histology, as well as with
measurement of ROS metabolites in culture media using HPLC.
Results: Functional responses in the experimental arthritis model, including increased nociceptive responses
(thermal and mechanical hyperalgesia and allodynia), knee joint temperature reflecting local blood flow, and spinal
cord ROS elevations were reduced by the ROS scavenger PBN after intraperitoneal pretreatment. Increases in TRPV1
and ROS, generated by synoviocytes in vitro, were reciprocally blocked by TRPV1 antagonists and the ROS
scavenger. Further evidence is presented that synoviocyte responses to ROS and TRPV1 activation include increases
in TNFa and COX-2, both measured as an indicator of the inflammation in vitro.
Conclusions: The results demonstrate that contributions of ROS to pronociceptive responses and neurogenic
inflammation are mediated both centrally and peripherally. Responses are mediated by TRPV1 locally in the knee
joint by synoviocytes, as well as by ROS-induced sensitization in the spinal cord. These findings and those of others
reported in the literature indicate reciprocal interactions between TRPV1 and ROS play critical roles in the
pathological and nociceptive responses active during arthritic inflammation.
Background
An emerging awareness in the field of neuroimmunity is
the close physiological tie between the activation of
transient receptor potential vanilloid type 1 (TRPV1) ion
channels and ROS formation [1-6]. Reactive nitroxida-
tive species (ROS - superoxide anion, hydrogen perox-
ide, hydroxyl, nitric oxide and peroxynitrite radicals) are
highly reactive molecules which in low concentrations
(5-10 μM) are required for many cellular regulatory
mechanisms. The TRPV cation channels are well known
activators of nociceptive responses and have also been
implicated in direct mediation of inflammatory events
[7]. Previous studies have shown reduced sensitization
responses in the complete Freund’s adjuvant (CFA)
hindpaw inflammation model with TRPV1 antagonists
in physiological dose ranges [8,9] as well as in TRPV1
knockout mice [10]. The TRPV1 agonist, capsaicin, is in
clinical use in concentrations sufficient to inactivate C
fiber nerve terminal endings producing analgesic effects.
Tissue injury rapidly initiates oxidative stress leading
to intracellular production of excessive ROS levels, such
as the reactive molecule H2O2 [11], which increases the
likelihood of extracellular spread. Evidence supports the
potential for ROS themselves to activate TRPV1 cation
channels after conformational change of this integral
membrane protein [12], directly increasing plasma
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membrane permeability to calcium ions [12,13]. For
example, footpad injection of H2O2 has been shown to
produce pain related behaviour through TRPV1 depen-
dent and independent mechanisms [14]. ROS activation
of TRPV1 on vascular membranes also increases local
blood flow [15]. Thus, increasing and persisting levels of
ROS have a dramatic impact on tissue and cellular func-
tion associated with inflammation.
The TRP superfamily of ion channels is implicated in
the pathogenesis of arthritis. Their multimodal activa-
tion occurs with decreasing pH, osmolar changes,
mechanical pressure, heat, cold, and noxious biochem-
icals, stimuli all very relevant to joint physiology and
pathology. While it is well known that TRPV1 channels
are found on primary afferent nerves in the periphery
[16,17], we have recently characterized and described
several functional TRP channels (TRPV1, TRPV4 and
TRPA1) present on human synoviocytes [18,19]. Syno-
viocytes line the joint capsules and in healthy individuals
produce the cushioning synovial fluid. As immuno-
responsive cells they also secrete inflammatory media-
tors in inflamed and injured joints.
The current study was initiated to gain a better appre-
ciation of reciprocal interactions between TRPV1 chan-
nels and ROS generation that contribute to neurogenic/
neuroimmune inflammation and nociceptive responses.
Results
To examine ROS and TRPV1 interactions, two arthritis
models were used in the present study including (a)
in vivo inflammation of the knee joint in rats induced
by injecting 3% kaolin and 3% carrageenan (k/c) directly
into the knee joint injection and (b) in vitro human
clonal type B synoviocytes (SW982) and primary syno-
viocytes harvested from clinic patients with active
arthropathies [19]. The first approach was to demon-
strate whether modulation by ROS scavengers would
reduce the hypersensitized responses in animals with k/
c inflamed knee joints. We examined not only the role
of ROS in inflammation through the generation of sensi-
tized behavioral responses, but also the ability of ROS
scavengers to reduce the generation of ROS in the
spinal cord dorsal horn.
ROS Scavenger Reduces Knee Joint Temperature But Not
Circumference
Baseline measurements of knee joint temperature, cir-
cumference, and nociceptive behaviors were conducted
in male Sprague Dawley rats (n = 8). Each animal served
as its own control in a repeated measures analysis of
variance experimental design (Mann Whitney U post-
hoc testing) with the significance level set at p < 0.05.
The rats received intrathecal administration of the ROS
sensitive dye, dihydroethidium (DHE, 50 μl of 100 μM).
The following day, half of the animals received an intra-
peritoneal (i.p.) injection of the ROS scavenger PBN
(100 mg/kg) and half received saline i.p. The left knee
joints (condyle fossa) of the hindlimbs of the anesthe-
tized rats were injected 1 h later with 3% carrageenan
(plant product and irritant) and 3% kaolin (clay silt)
(100 μl in sterile saline) to produce an acute inflamma-
tion confined to the one knee joint.
Four hours after the k/c injection, the inflamed knee
joint produced an ipsilateral abnormal stance with
curled toes and foot eversion at rest. There was a
slightly noticeable limp when animals moved slowly.
There was no discernable difference from controls in
rapid locomotion. Knee joint circumference increased
1 cm on average (4-8 h) on the injected left knee but
not on the uninjected knee as previously reported [20].
Skin temperature was elevated over baseline in both
knees indicating mirror blood flow increase despite neg-
ligible change in joint circumference in the uninjected
knee joint (Fig. 1, hatched bars, p < 0.05; 4 h).
In animals pre-treated i.p. with ROS scavenger, PBN,
circumference of the injected knee in animals was also
increased by a similar amount (0.78 cm ± 0.1 s.e.m., 4-8
h). However, skin temperature of both knees remained
at baseline 4 h after induction of inflammation (Fig. 1,
black bars). Core body temperature was not increased
over baseline in any of the animals (data not shown).
Figure 1 Knee Joint Temperature Increase is Blocked by ROS
Scavenger PBN. Right and left knee joint temperature (°C) at
baseline and 4 h after k/c induction of left knee joint inflammation
(Arth) in rats pre-treated i.p. with saline (n = 4) or the ROS
scavenger, PBN (n = 4). The PBN provided protection from
significant increase in knee joint temperature typical of this arthritis
model. Temperature increase in both knees is indicative of a
centrally mediated “mirror” effect on regional blood flow. Core body
temperature measured with a rectal thermometer was not increased
over baseline.
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ROS Scavenger Reduces Nocifensive Behaviors
Mechanical Allodynia and Hyperalgesia
Behavioral testing of mechanical sensitivity four hours
after the induction of the knee joint inflammation was
done by applying von Frey filaments of two strengths
(10 mN and 47 mN) upward through a wire mesh table-
top onto the footpad of the animals. Ten bending
strokes (5 sec) were applied to different sites on the
footpad of the hindlimbs. The pressure of the 10 mN
filament was barely detectable to human skin. Behavioral
testing on the bottom of the footpad clearly differen-
tiated the sensitized responses as secondary mechanical
allodynia in response to the weaker 10 mN stimuli and
secondary mechanical hyperalgesia for the stronger
47 mN stimuli.
The percent of responses to strokes applied to the
footpad on the side with the inflamed knee were signifi-
cantly increased in animals pre-treated with saline com-
pared to their own baseline responses. The percent
responses increased from 5 ± 1.7% at baseline to 66.6 ±
11.9% (p < 0.01) at 4 h post (Fig. 2A). Responses were
unchanged on the footpad of the uninjected side.
Pre-treatment with ROS scavenger PBN eliminated the
sensitized responses. The level of sensitivity was not sig-
nificantly altered compared to baseline in animals with
inflamed knees pretreated with PBN (i.p.). The mean
difference in percent response between the saline and
PBN treatment groups at 4 h was significant (66.6 ±
11.9 vs 10 ± 1.9%, p < 0.01). For the stronger 47 mN
bending force monofilament, the responses on the foot-
pads in animals with inflamed knee joints were
increased from 48.3+12% to 85+4.2%, p < 0.05). Pre-
treatment with PBN significantly reduced the response
to mechanical stimulation below baseline (66.7 ± 6.1 to
30 ± 7.9%, p < 0.05). The response differences for saline
versus PBN treated animals was also significant (85 ±
4.2 vs 30 ± 7.9, p < 0.01).
Heat Hyperalgesia
Sensitivity to heat was tested 5 h after induction of knee
joint inflammation with the hotplate (50°C). Responses
to the heat stimulus indicating a termination endpoint
for the trial included paw flicking, licking or jumping at
which point the rats were immediately removed from
the hotplate. It was never necessary to employ the
20 sec maximal cut off time in this study. In animals
pre-treated with PBN, response latency to thermal sti-
muli remained near baseline. Response times for the
appearance of complex behaviours to the novel heated
surface stimulus were recorded. Saline treated animals
had significantly reduced response times compared to
baseline for (14.4 ± 1.1 vs 7.8 ± 0.7 sec, p < 0.01)
(Fig. 2B), while the response times of PBN treated ani-
mals were not different from their baseline (13.5 ±
0.8 vs 14.2 ± 2.8 sec, p>0.05). The response time was
Figure 2 Pain Related Behaviors are Blocked by PBN . A -
Mechanical Hyperalgesia/Allodynia are Blocked by ROS
Scavenger PBN. Responses to mechanical stimulation with two
strengths of von Frey filaments are shown for rats at baseline and 4
h after k/c injection into the left (L) knee joint. Secondary
mechanical allodynia is tested on the footpad with the weak 10 mN
stimulus (upper bar chart), and secondary mechanical hyperalgesia
is observed with the stronger 47 mN stimulus (lower bar chart).
Percent paw withdrawal frequency (PWF) is significantly increased at
4 h after i.p. pre-treatment with saline (n = 4). The hypersensitive
responses are blocked by the ROS scavenger, PBN, injected
intraperitoneally 2 h before induction of the knee joint
inflammation (n = 4). B - Hotplate Response is Blocked by ROS
Scavenger PBN. Response times in seconds (s) are shown for the
hotplate test at baseline and five hours after k/c induced left (L)
knee joint arthritis (Arth) in rats pre-treated with saline (n = 4) or
ROS scavenger, PBN (n = 4). The PBN pre-treatment administered i.
p. 1 h prior to induction of arthritis prevented development of
secondary thermal hyperalgesia observed in the saline treated
group.
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also significantly reduced at 4 h for saline treated ani-
mals versus the PBN treated animals with knee joint
inflammation (7.8 ± 0.7 vs 14.15 ± 2.8 sec, p < 0.05).
These sensitized responses to a novel heat stimulus indi-
cate central sensitization mechanisms involving neurons
in the dorsal horn of the spinal cord and higher pain
processing centers.
ROS Scavenger Reduces ROS Production in Spinal Cord of
Rats with Inflamed Joints
After induction of knee joint inflammation, ROS was
observed in the spinal cord of animals pre-injected with
the ROS indicator dye DHE (Fig. 3A). No fluorescent
DHE was observed in the spinal cord of control animals.
The ROS indicator was localized particularly in associa-
tion with large cells and in the myelin sheaths of incom-
ing afferent nerve fiber bundles (arrows). Localization in
nerve bundles implies that ROS derived from oligoden-
droglia are important in glial/neuronal interactions dur-
ing emerging inflammation induced pronociceptive
states. Systemic pre-treatment with the PBN greatly
reduced visualization of the ROS indicator in the spinal
cord, concomitant with the decreased scores for noci-
ceptive behaviour and joint temperature in animals with
inflamed knee joints (Fig. 3B).
TRPV1 Mediated ROS Generation: HPLC Measurement of
ROS Metabolites from SW982 Synoviocytes In Vitro
TRPV1 channels have previously been characterized on
clonal human type B SW982 synoviocytes using RT-
PCR, Western blot and calcium mobilization after acti-
vation with TRPV1 agonists, capsaicin and resinifera-
toxin [18,19]. In the present study, the clonal type B
synoviocytes were utilized as an in vitro model of knee
joint inflammation since these synoviocytes produce
inflammatory mediators when activated with another
channel activator, glutamate [21]. Unstable hydroxyl
radicals (HO•) were induced by TRPV1 agonist resini-
feratoxin in cultured clonal SW982 synoviocytes. While
the unstable ROS were not measureable, metabolites
2,3- and 2,5-dihydroxybenzoic acid (2,3- and 2,5-DHBA)
were measureable in the cell culture media by HPLC
with electrochemical detection (Fig. 3C). Cell plates
were incubated (37°C × 6 h, n = 4) in saline bath con-
taining 2.5 mM salicylic acid with 100 nM resinifera-
toxin or vehicle (n = 4). Samples of extracellular
solution were taken and analyzed for ROS metabolites.
The TRPV1 activation of the SW982 cells produced a
statistically significant 1.68-fold increase in extracellular
ROS metabolite 2, 5-DHBA (7.8 ± 0.9 pg/ml, p < 0.05)
compared to control cells treated with the vehicle (4.6 ±
0.4 pg/ml).
Figure 3 ROS Generation. A - Lumbar Spinal Cord after K/C
Induced Knee Joint Inflammation. Cumulative generation of ROS
is detected by conversion of the fluorescent indicator DHE in the
dorsal horn of the L4 spinal cord segment in rats with k/c induced
knee joint arthritis (6 h) (n = 4). B - ROS Generation Is Blocked by
ROS Scavenger PBN. Much less DHE is observed in spinal cords of
rats pretreated i.p. with ROS scavenger, PBN, 1 h prior to induction
of knee joint inflammation with k/c (n = 4). Tissues were collected
from paraformaldehyde perfused rats 6 h after induction of k/c knee
joint arthritis. C - TRPV1 Agonist Induces ROS in Human SW982
Synoviocytes. Enhanced hydroxyl radical (HO•) production is
induced by treatment of cultured clonal human SW982
synoviocytes with TRPV1 agonist resiniferatoxin. SW982 cells were
incubated in bath saline (37°C) containing 2.5 mM salicylic acid and
100 nM resiniferatoxin (res) (n = 4) or vehicle (cont) (n = 4). After a
6 h incubation samples of extracellular solution were analyzed for
stable ROS metabolites, 2,3- and 2,5-dihydroxybenzoic acid (2,3-
DHBA and 2,5-DHBA), by HPLC with electrochemical detection as
pictogram per microliter (pg/μl).*- indicates statistically significant
difference (p < 0.05) between control and resiniferatoxin treated
cells.
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TRPV1 Mediated ROS Generation is Blocked by TRPV1
Antagonist and ROS Scavenger: Live Cell Imaging of ROS
Sensitive Intracellular Dye
Clonal Human Type B SW982 Synoviocytes
Cellular ROS responses were visualized with live cell
imaging in cells pre-loaded with 5- (and -6)-chloro-
methyl-2’,7’-dichlorodihydrofluorescein diacetate, acetyl
ester (CM-H2-DCFDA). The intracellular reactive oxy-
gen species increases were detected by the oxidation of
CM-H2-DCFDA and stimulated conversion to the fluor-
escent indicator 2’-7’-dichlorofluorocein (DCF). As
illustrated in Figure 4, fluorescent cell intensity at base-
line (Fig. 4A) was increased after addition of resinifera-
toxin to the clonal human type B SW982 synoviocytes
(Fig. 4B). The quantitative measure of the average fluor-
escent DCF emission in response to resiniferatoxin (100
nM, arrow) is shown plotted over time (Fig. 4C, upper
trace). A 2-fold increase in ROS production generated
by a representative synovial cell cultures after resinifera-
toxin stimulation is shown for comparison to the
response plotted for fluorescent DCF emission of a non-
stimulated cell culture (Fig. 4C, lower trace) that
Figure 4 TRPV1 Activates ROS Production - Live Cell Imaging. A-D Clonal SW982 Synoviocytes. A, B- Live cell ROS imaging in SW982
synoviocytes before (A) and 15 min after (B) activation of TRPV1 with resiniferatoxin (100 nM). At least five of the cells in this view (arrows)
demonstrated a significant increase in DCF fluorescence over time, reflecting a TRPV1-mediated oxidative burst. C - Quantification of fluorescent
emission for the ROS response to resiniferatoxin over time (min) is shown in the plot. Cells were pre-loaded with 4 μM 5-(and-6)-chloromethyl-2’,
7’-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) for 20 min at room temperature. The cellular uptake and ROS converted 5-(and-6)-
carboxy-2’,7’-dichlorofluorescein (DCF) fluorescence was measured by live cell imaging for 30 min. Resiniferatoxin (100 nM) was added by bath
perfusion for 4 min as indicated by the arrow. Graph shows typical fluorescence signal acquired from one responsive and one non-responsive
cell out of 48 simultaneously recorded cells. D - Averaged DCF fluorescent emission responses to saline, capsaicin (1 μM), or capsaicin plus
TRPV1 antagonist SB-366791 (30 μM) are shown in the plot (arbitrary units) over time (min). Fluorescent emission was significantly increased in
cells activated with capsaicin. ROS induced fluorescent DCF emission in cells pre-treated for 10 min with the TRPV1 antagonist and then
activated with capsaicin were not significantly increased over saline treated cells. Numbers of cells are indicated in parenthesis averaged from
three experiments. E-F TRPV1 Mediated ROS Production in Primary Human Synoviocytes from Two Patients. Live cell imaging was used to
visualize ROS generation over time (min) after stimulation with TRPV1 agonist resiniferatoxin and conversion of a ROS sensitive dye to
fluorescent DCF in the synoviocytes. Primary human synoviocytes were acclimated 3 weeks in culture after harvesting from knee joints of
patients with active arthropathies (osteoarthritis, pseudogout). Resiniferatoxin (100 nM) was added in bath perfusion for 4 min at the time
indicated by arrow. Fluorescent image (E) and quantitative graph (F) show typical fluorescence signal acquired from one responsive (b) and one
non-responsive (a) out of 85 simultaneously recorded cells. A total of 68 cells responded to the TRPV1 agonist out of 162 total cells imaged from
the two patients.
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displays only spontaneous oxidation of the DCF. The
responses to resiniferatoxin were dose-dependent (not
shown) and 56% of the cells were activated. The
responses to resiniferatoxin were blocked by pretreat-
ment with TRPV1 antagonist, capsaizepine (10 μM), and
resulted in only 2% of the cells responding.
The responses to resiniferatoxin were also blocked by
PBN (2 mM pretreatment for 2 h). Treatment with cap-
saicin also increased ROS in the SW982 cells (Fig. 4D,
upper trace). Capsaicin responses were blocked by
TRPV1 antagonists, capsaizepine and SB-366791 (30
μM). The averaged responses for all cells tested are
shown (Fig. 4D, middle trace). Treatment with TRPV1
agonists capsaicin or resiniferatoxin yielded no respon-
sive cells after pre-treatment with the ROS scavenger
PBN (2 mM pretreatment for 2 h).
Human Primary Synoviocyte Cultures
The validity of the idea that TRPV1 activation generates
ROS was also tested using human primary synoviocyte
cultures harvested from clinical synovial fluid samples
drawn from the knee joints of patients with active
arthropathies (osteoarthritis and acute pseudogout).
After three weeks acclimation in culture to eliminate
non-fibroblast-like cells, ROS production by the primary
human synovial fibroblast-like cells was quantified with
live cell imaging of DCF fluorescence after activation
with TRPV1 agonist, resiniferatoxin. Fluorescent ima-
ging (Fig. 4E) and the quantitative graph (Fig. 4F) show
typical fluorescence signal acquired from (a) one non-
responsive and (b) one responsive synoviocyte out of 85
simultaneously recorded cells. Resiniferatoxin (100 nM)
was added in bath perfusion for 4 min at the time indi-
cated by arrow on the graph. The resiniferatoxin
initiated ROS production in 42% of the synoviocytes
tested in the primary cultures harvested from the clinic
patients with active arthropathies.
ROS Donors Generate ROS and Increase TRPV1 in
Synoviocytes
For comparison, ROS production over time after incu-
bation with H2O2 was tested as shown in Fig. 5. An oxi-
dative burst activated by H2O2 (1 mM) was prevented
when cells were pretreated with the ROS scavenger,
PBN (2 mM, 2 h). The average DCF fluorescence (± s.e.
m.) was plotted from control (Fig. 5A, lower trace) cells
pretreated with PBN as well as from H2O2 activated
cells, with and without PBN (Fig. 5A middle and upper
trace, respectively). Treatment with the ROS scavenger
alone had no effect on the synovial cell cultures beyond
the gradual spontaneous oxidation of the dye seen over
time in vehicle treated cells (Fig. 5A, lower trace).
Activation of synoviocytes with the ROS donor,
tBOOH, increased the immunocytochemical staining
intensity for TRPV1 almost two-fold (1.9×) within
30 min (Fig. 5B) (control 115.6 ± 10.5 versus activated
219.8 ± 41.49 arbitrary units, p < 0.05). This increase
was blocked by the TRPV1 antagonist, SB-366791
(30 μM)(134.5 ± 20.55). The increase in TRPV1 protein
was measureable with Western blot at 8 h normalized
with b-actin controls (Fig. 5C).
TRPV1 and ROS Generate COX-2, RANTES, TNFa and
Additional TRPV1
Stimulation of human clonal SW982 synoviocytes with
resiniferatoxin, greatly increased immunocytochemical
staining for the inflammatory enzyme COX-2 (Fig. 6A)
and the chemokine RANTES (not shown) visualized at
24 h. The TRPV1 induced increase in COX-2 staining
was reduced by pre-treatment with either TRPV1
antagonist capsazepine (5 μM) or the ROS scavenger
PBN (2 mM). Neither inhibitor had an effect on the clo-
nal synoviocytes when applied in otherwise unstimulated
cells. Significantly increased staining for TNFa was also
evident within 30 min in synoviocytes activated with
ROS donor tBOOH (100 μM) (Fig. 6B). The increase in
TNFa levels after activation with the ROS donor was
less in the presence of the TRPV1 antagonist SB-36791
(30 μM).
Discussion
ROS and TRPV1 as Initiators of Neurogenic Inflammation
Induced Hypersensitivity
Central Sensitization
TRPV channels respond to thermal, chemical, pH,
osmotic, and mechanical stimuli, with an inward current
carried predominantly by calcium and sodium ions. All
of these TRPV1 channel activators are abundant in
inflamed and injured tissue, as are ROS. The current
findings indicate that the ROS scavenger, PBN, nor-
malizes the inflammation induced behavioral responses
tested on the footpad of the affected hindlimb in the
knee joint k/c monoarthritis model. Thus, inhibition of
ROS generation centrally and perhaps peripherally
improves the adverse nociceptive outcomes in this
model.
The generation of excess ROS in the spinal cord is
observed histologically in close association with the
incoming large myelinated afferent nerve fiber bundles.
Glial cell generation of ROS would provide a means of
direct sensitization of myelinated afferent nerve fibers
locally in the dorsal horn, extending the direct influence
of the afferent nerves bringing nociceptive input to the
spinal cord from the knee joint. Knee joint afferents are
reported to be primarily unmyelinated fibers [22,23]. It
is likely that ROS contribute to the primary afferent and
spinal cord mechanisms detected as secondary thermal
and mechanical sensitization by testing the footpad of
the animals with knee joint inflammation in this and a
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previous study [14]. ROS scavengers have been shown to
reduce the spinal cord long-term potentiation mechan-
ism that contributes to central sensitization [24].
Peripheral Sensitization
In the current study, we have shown that TRPV1 activa-
tion of local synoviocytes is also highly relevant to the
pathophysiology in inflamed joints through interactions
with reactive oxygen species. These processes include
the mirrored increase in blood flow likely responsible
for bilateral knee joint temperature increase in this
arthritis model. Capsaicin mediated increase in periph-
eral blood flow has been shown to be reduced in
TRPV1 knockout mice [15]. Experiments have shown
capsazepine inhibits the release of calcitonin gene-
related peptide (CGRP) from cardiac sensory nerves that
physiologically respond to a decrease in pH of the perfu-
sion solution in isolated heart preparations [25,26]. This
CGRP release along with substance P initiates protein/
plasma extravasation and edema, increased blood flow
and resultant temperature increase.
The overall conclusion of the in vivo study is that
ROS themselves act in sensitization processes contribut-
ing to further inflammation and increased nociception.
These findings contribute to an emerging concept that
elevated levels of ROS play a critical role in the periph-
eral and central sensitization underlying persistent pain
and are potentially TRPV1 mediated. To further address
and support this concept in the context of the local per-
ipheral microenvironment in inflamed joints, further
studies with in vitro synoviocyte models were done that
provided evidence of reciprocal interactions between
TRPV1 activation and ROS generation.
TRPV1 Mediated ROS Generation in Synoviocytes
We have previously identified, characterized and
sequenced TRPV1 and TRPV4 isoforms on clonal and
primary human synoviocytes [18]. Live cell imaging of
calcium mobilization in the synoviocyte cultures was
conducted in the presence of TRPV1 agonists and rapid
changes in bath temperature or pH. In the current
study, live cell imaging of synoviocyte cultures with a
ROS sensitive dye indicated that TRPV1 agonists can
elicit ROS elevations. ROS generation in clonal synovio-
cytes was observed in response to TRPV1 agonists cap-
saicin and resiniferatoxin, and hydrogen peroxide. These
enhanced ROS responses were blocked by a TRPV1
Figure 5 ROS Activation Increases TRPV1. A - H2O2 Oxidative Burst Is Blocked by PBN. An oxidative burst in SW982 synoviocytes was
activated by the application of H2O2 (1 mM, arrow) to the media (upper trace). The generated ROS were detected with live cell imaging of the
oxidative conversion of the ROS sensitive CM-H2DCFDA fluorophore to DCF over time (min). Presence of the ROS scavenger PBN (2 mM for 2 h,
middle trace) in the media prevented the oxidative burst and detected ROS levels were similar to the spontaneous levels seen with the addition
of vehicle (with PBN, lower trace). The small error bars are obscured by the large symbols. Numbers of cells are indicated in parenthesis in the
legend imaged in three experiments. B - ROS Induced Increase in TRPV1. Immunostaining for TRPV1 in SW982 synoviocytes was significantly
increased (arbitrary units) compared to control cultures within 30 min after treatment with the ROS donor, tBOOH. The TRPV1 antagonist, SB-
366791, inhibits the staining increase. The effect of the tBOOH when combined with the SB-366791 (30 μM) was not significantly different from
the controls. All experiments were done in triplicate. *p < 0.01 compared to the control cultures. C - The TRPV1 expression increase was
measureable by Western blot analysis at 8 h. The protein level (normalized with b-actin) in SW982 synoviocytes was increased almost 2-fold after
pulsing with 1 mM H2O2 for 10 min. All experiments were done in triplicate.
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antagonist or ROS scavenger, PBN, indicating that ROS
generation in synoviocytes is TRPV1 mediated in the
experimental conditions utilized.
TRPV1-Mediated ROS Increases Inflammatory Mediators
Inflammatory products are produced locally in inflamed
joints by activated synoviocytes. In the current study, we
have detected activation responses mediated by TRPV1
and ROS that include increases in COX-2, RANTES and
TNFa. An increase of COX-2 expression in synoviocyte
cultures was blocked by either PBN or a TRPV1 antago-
nist. The ROS induced increase in TNFa was blocked
by the ROS scavenger.
Conversely, ROS production in synovial fibroblasts
harvested from patients has been shown in a previous
study to be increased significantly by IL-6 and inhibited
by methotrexate [27]. Modulation of cytokine synthesis
and ROS production may contribute to the therapeutic
effects of the anti-arthritic agent, methotrexate. These
results suggest that the inflammatory events in the syno-
vium of patients with rheumatoid arthritis are augmen-
ted locally by ROS generation and the subsequent
production of cytokines. ROS released by chondrocytes
during inflammation of the synovial membrane have
also been associated with cartilage degradation in
osteoarthritis (for review see [28]).
We also report here that synoviocytes increase TRPV1
protein expression after administration of ROS donors.
We have shown previously that TNFa induces increases
in TRPV1 in synoviocytes [19], and that TRPV1
Figure 6 TRPV1 and ROS Mediated Increase in Inflammatory Mediators. A - COX-2 Staining Increase Is Blocked by ROS Scavenger PBN
in SW982 Synoviocytes. Clonal SW982 synoviocytes are activated by TRPV1 agonist, resiniferatoxin, resulting in an increase in immunostaining
for inflammatory mediator producing enzyme, COX-2. The COX-2 expression was blocked by either the TRP agonist capsazepine or the ROS
scavenger, PBN, while the blockers alone had no effect. All experiments were done in triplicate. B- ROS Donor Induced TNFa Expression
Increase Is Inhibited by TRPV1 Antagonist, SB-366791. Synoviocytes activated by ROS donor, tBOOH, also have increased immunoreactivity
for the inflammatory mediator, TNFa, within 30 min that is significantly increased over control cultures. The effect of the tBOOH was reduced
slightly by the TRPV1 antagonist, SB-366791. All experiments were done in triplicate and intensity measurements (arbitrary units) determined
with the MetaVue computer-assisted imaging system.* p < 0.05 and ** p < 0.001 compared to the control cultures.
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activation increases TNF receptors (TNFR1) in dorsal
root ganglia (DRG) through a ROS mediated signalling
pathway [29].
It is well known that inflammatory mediators and pro-
ducts (Ex. TNFa, COX-2) can directly sensitize periph-
eral nerve endings [30-37], suggesting a potential direct
interaction between synoviocytes and peripheral nerves.
A metabolite of COX-2, prostaglandin E2, is a compo-
nents of the “inflammatory soup” used in many studies
to activate peripheral nerves and was used combined
with low pH in studies by Peter Reeh and colleagues
[38]. Bolyard and colleagues have found that continuous
exposure of rat sensory neurons to “inflammatory soup”
results in continued sensitization [39]. We have found
previously that afferent innervation contributes to knee
joint inflammation since cutting dorsal roots or spinal
cord block of glutamate receptors and dorsal root
reflexes reduce inflammation in half [20,40-42]. It has
been shown previously by others that desensitization of
TRPV1 in the knee joint with millimolar doses of resini-
feratoxin reduces hyperalgesia, locomotor effects and
joint circumference in a similar knee joint inflammation
model [43]. These findings suggest that tissue inflamma-
tion and injury would activate TRPV1 ion channels and
excess ROS would be generated to increase nociceptive
responses and other inflammatory response processes.
Other studies have shown that capsaicin acting through
TRPV1 generates ROS production in several cell types,
including breast epithelial, hepatoma and embryonic kid-
ney cells [1-3], but TRPV1 may suppress ROS formation
in glioblastoma cells [4]. Both TRPV1 and P2X ion chan-
nels mediate the sensory transduction of ROS, especially
H2O2 and hydroxyl radicals (•OH), by capsaicin-sensitive
vagal lung afferent fibers [5]. Evidence from several stu-
dies has shown that free oxygen radicals stimulate sen-
sory nerve endings through direct actions on capsaicin
activated ion channels on primary afferent nerve endings
[6,24,44-46]. These studies have shown that administra-
tion of capsazepine or a nonspecific TRPV blocker,
ruthenium red, prevents afferent nerve activation by free
oxygen radicals. Increased primary afferent nerve activity
is known to evoke central sensitization as seen following
capsaicin injection [47], peripheral injury [48], or inflam-
mation [49]. Importantly, these previous studies have
demonstrated that administration of capsazepine has no
effect on the baseline activity of either vagal or sympa-
thetic cardiac afferents, but does abolish the response of
afferent nerve fibers to capsaicin, H2O2, and xanthine +
xanthine oxidase.
Conclusions
The data shown here illustrate that central sensitization
and increased temperature responses in an experimental
monoarthritis model can be limited by systemic
administration of a ROS scavenger. Spinal cord ROS con-
tributing to the sensitized behavioural responses were
concomitantly reduced by the scavenger. Examination of
human clonal and primary synoviocytes in vitro in the
current study found, more importantly, that TRPV1 acti-
vation represents an important potential peripheral
mechanism initiating the generation of ROS and the
inflammatory products, COX-2 and TNFa, by the resi-
dent synoviocytes that are known to proliferate in
arthritic joints. Reciprocally generated increases in ROS,
TRPV1 activation and proinflammatory products by
synoviocytes were detected after an induced oxidative
burst or TRPV1 activation suggesting a potential
mechanism for conversion to a more chronic state of
inflammation and pain. Together these exciting data
implicate TRPV1 ion channels and ROS as interactive
partners in neuroinflammatory processes both centrally
and peripherally. Their interactions lead to intensification
of nociceptive responses and inflammatory responses
with potential to damage inflamed joints. Thus, the data
support the benefits of agents limiting or eliminating the
increases in TRPV1 mediated ROS as a novel adjuvant
therapy for more comprehensive treatment of the persis-
tent pathologic pain and inflammation of arthritis.
Methods
All experimental research was performed under protocol
approved by the Institutional Animal Care and Use
Committee. All experimental research followed institu-
tional, national and internationally recognized guide-
lines. All animals were housed in AAALAC and USDA
approved facilities.
Induction of Arthritis and Intrathecal ROS Indicator Dye
Injection
All of the rats were anesthetized with isoflurane and
polyethylene tubing inserted through the foramen mag-
num intrathecally to the T10 level of the spinal cord for
intrathecal injection of the ROS sensitive dye, DHE
(dihydroethidium, Sigma; 50 μl in saline:DMSO, 1:1
injected intrathecally). The following day, half the ani-
mals were injected i.p. with the ROS scavenger PBN
(100 mg/kg, Sigma) and the other half injected i.p. with
saline. One hour later, the animals were anesthetized
and their left knee joint injected with 3% carrageenan
(plant product and irritant) and 3% kaolin (clay silt)
(100 μl in sterile saline) to produce an acute inflamma-
tion (4-8 h) confined to the knee joint [20]. Inflamma-
tion developed in the knee joint within 4 h, and pain
related behaviour was assessed.
Assessment of Nociceptive Responses and Inflammation
Baseline measurement of circumference, knee joint tem-
perature and nociceptive behaviours were recorded in
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male Sprague Dawley rats (250-350 g, n = 8), which
served as their own controls in a repeated measures
intra-subject experimental design. Experimental mea-
sures for comparisons of inflamed vs normal joints in
rat included:
(1) Assessment of knee joint circumference and tem-
perature of the skin over the lateral surface of the knee.
Knee joint temperature was assessed in rats with a small
thermoprobe placed on the skin over the knee joint
attached to a thermometer with rapid digital readout
(Digi-Thermo, Fisher). Random skin sites confirmed
that only the knee joint temperature was elevated, bilat-
erally. Core body temperature was measured with a rec-
tal thermometer. (2) Pain related nocifensive behavioral
assessment of nociceptive sensitization was done with
hotplate and von Frey fiber tests, standard tests of ther-
mal and mechanical sensitivity. The rats were placed
into the Analgesiometer hotplate device with a constant
floor temperature of 50°C. Animals were immediately
removed when they displayed a flinching, paw flipping
or stepping behaviour. A maximal time limit of 20 sec
was set when unresponsive animals would be removed
from the setup.
For mechanical sensitivity testing, animals were accli-
mated for 30 min to a cubicle placed on a wire mesh
table top. Paw withdrawal responses to two von Frey
monofilaments (10 and 47 mN, Semmes-Weinstein
Anesthesiometer Kit #18011, Wood Dale, IL), were
recorded two days before induction of arthritis and 4 h
after the induction by an observer who was blind to the
animals’ condition. A single trial consists of 10 applica-
tions of the filament applied once every second. Trials
were repeated no less than 3 min apart to allow the rat
to cease any response and return to an inactive posture.
Data are presented as a mean response (1-10) and
plotted against time after induction of arthritis. An
increase in response frequency reflects secondary
mechanical allodynia for the 10 mN monofilament and
secondary mechanical hyperalgesia for the 45 mN
monofilament.
Detection of ROS in Tissue Sections
ROS in the spinal cord dorsal horn were visualized
using a detector dye dihydroethidium (DHE, Molecular
Probes, Eugene, OR). The dye is converted to a stable
fluorescent product by ROS and allows visualization of
ROS accumulated in spinal cord of rats during the time
after knee joint inflammation. The DHE (50 μl, 100 mM
in DMSO:saline, 1:1) was injected intrathecally through
the foramen magnum of anesthetized rats onto the lum-
bar level of the spinal cord with a blunt 30 G needle
attached to a 250 μl Hamilton syringe. Animals were
allowed to recover and knee joint inflammation was
induced 24 h later. The tissue stable fluorescent ROS
indicator DHE was visualized in aldehyde fixed and cut
spinal cord at the conclusion of the behavioral study, i.e.
6 h after induction of arthritis. Animals were anesthe-
tized with an injection of Sleepaway pentobarbital solu-
tion and transcardially perfused with 0.9% heparinized
saline (500 ml) followed by 4% phosphate buffered par-
aformaldehyde (1000 ml). The spinal cord was dissected,
cryoprotected overnight in 30% buffered sucrose and
frozen sectioned (15 μm). Spinal cord sections were cut
and mounted on gel coated slides and DHE fluorescence
visualized with rhodamine filter settings on a Nikon
E1000 photomicroscope equipped with the MetaVue
Optical Imaging system.
Human Clonal and Primary Synoviocyte Cultures
Clonal Synoviocytes
A clonal fibroblast-like cell line SW982, derived from a
human synovial sarcoma, was obtained through Ameri-
can Type Cell Collection (ATCC, Bethesda MD, #HTB-
93). Immunocytochemical studies have ascertained that
these cells are vimentin positive, smooth muscle actin
positive and CD11b negative, consistent with the pheno-
type of type B synovial cell fibroblasts [19]. In addition
the SW982 cells did not stain with anti-neuronal nuclei
(neuN) antibody.
Clonal cells were maintained and grown in Leibowitz
medium containing 10% heat-inactivated fetal calf serum,
2 mM L-glutamine, 1000 U/ml penicillin G and 1000 pg/
ml streptomycin (Invitrogen, Carlsbad, CA or Gibco,
Grand Island, NY). Thirty percent conditioned media
was retained at each fresh media change. Cells were
maintained in a humidified cell incubator at 37°C and 5%
CO2. Cells were split using 0.25% trypsin/0.02% EDTA
for disruption and plated in a 24 well plate on glass slides
at a density of 20-40,000 cells per well for immunocyto-
chemistry or plated on 15 mm circular quartz glass cov-
erslips at a density of 200,000 cells/mm3 for live cell
imaging. Clonal cells were used in passages 4-21.
Primary Synoviocytes
Primary cultures of surface-adherent synoviocytes were
established from synovial fluid derived from the dis-
carded sample of a clinical arthrocentesis procedure per-
formed on patients with acute pseudogout or
osteoarthritis, based on American College of Rheumatol-
ogy criteria and in accordance with the guidelines and
approved protocol of the University of Texas Medical
Branch Institutional Review Board. Cells were main-
tained in DMEM, 10% heated FBS, 2 mM L-glutamine,
and penicillin-streptomycin. Primary cultures were incu-
bated in a humidified cell incubator (37°C with 5% CO2
atmosphere) for 3 wk before testing. Cells were split
with 0.25% trypsin-0.02% EDTA for disruption and pla-
ted on 15 mm circular quartz glass coverslips at a den-
sity of 200,000 cells/mm3.
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Real-Time Live Cell Imaging of ROS
In the 24-48 h prior to experiments, cells were har-
vested and plated onto 15 mm quartz glass coverslips.
Standard bath solutions consisted of (in mM) 150 NaCl,
5.5 KCl, 1 MgCl2, 4 CaCl2, 5 glucose, and 10 HEPES,
adjusted to pH 7.4 at RT with NaOH (330 mosmol/l).
On the day of the experiment, primary or SW982 syno-
viocytes were pre-loaded with a ROS-sensitive dye, 2,7-
dichlorofluorescein diacetate (DCFDA, 2-4 μM for 30
min at a room temperature, Molecular Probes, Invitro-
gen, Eugene, OR), a non-fluorescent chemical oxidized
intracellularly by ROS to the highly fluorescent deriva-
tive DCF. After pre-loading, the cells were washed in a
physiological saline solution, allowed to stay from 30
min to 2 h at a room temperature, placed in a continu-
ously superfused thermoregulated chamber (Warner
Instruments, Hamden, CT) and then mounted to the
stage of inverted Nikon Diphot microscope for record-
ing. Application of chemicals onto individual cell was
achieved by gravity flow from a large-bore pipette placed
300-400 μm from the cell. The dye-loaded cells were
excited at 488 nm and emitted light collected using 490
nm long pass, or 535 nm (bandwidth 40 nm) filter.
Real-time live cell imaging at high power was done with
a Polychrome II monochromator (TILL Photonics,
Munich, Germany) controlled by X-chart software
(HEKA, Heidelberg, Germany) and with an ITC-18
computer interface (Instrutech, Port Washington, NY)
for single cell fluorescence excitation. The resulting
DCF emissions were detected with a Hamamatsu R928
photomultiplier. Imaging was performed in Dubecco’s
PBS (pH 7.4, RT) using a Nikon TE2000-S Eclipse quan-
titative fluorescence live-cell imaging system equipped
with a high sensitivity 12 digital monochrome cooled
Coolsnap ES CCD camera (Photometrics, Tucson, AZ).
Lambda LS illumination and a Lambda 10-B Smart
Shutter (Sutter Instruments, Novato, CA) were con-
trolled by Metafluor software (Molecular Devices, Sun-
nyvale, CA). Metamorph (Molecular Devices, Sunnyvale,
CA) software was used for digital image processing, and
Excel scientific software (SPSS, Chicago, IL) was used
for conversion and analysis of acquired data. Experi-
ments were repeated a minimum of three times each.
Preincubation of the SW982 cells with TRPV1 antago-
nists capsazepine (5 μM, Calbiochem, La Jolla, CA), SB-
366791 (30 μM, Tocris, Ellisville, MO) or ROS scaven-
ger, PBN (2 mM, Sigma, Chemical, St. Louis, MO) was
performed 2 h before addition of resiniferatoxin (100
nM) or capsaicin (1 μM, Tocris, Ellisville, MO). After
application of resiniferatoxin, the cells were incubated
for 2 h at 37°C in an incubator at ambient CO2. After 2
h, the cell culture supernatant was aspirated and
replaced with regular media or with regular media con-
taining capsazepine or PBN at concentrations noted
above. The cultures were then incubated overnight
(37°C, 5% CO2) prior to removal of supernatant for
Western blot analysis of ROS metabolites and immuno-
cytochemical localization of TRPV1, COX-2, and TNFa.
Measurement of ROS metabolites by HPLC
As an indicator of TRPV1 mediated ROS released into
the supernatant, ROS metabolites 2,5-DHBA and 2,3-
DHBA were trapped with salicylic acid [50] and the
samples analyzed by high performance liquid chromato-
graphy with electrochemical detection (HPLC-ECD).
Given that the hydroxyl radical is a short-lived, highly
reactive chemical, it cannot itself be collected and pre-
served in a sample tube. The salicylic acid trapping
agent (2.5 mM) reacts with the hydroxyl radical to pro-
duce DHBAs. The level of hydroxyl radical production
in response to the TRPV1 activation was compared to
that in media collected from control cultures from three
experiments. Comparison of the results based on the
quantities of increased 2,3-DHBA were considered reli-
able because there is some endogenous enzymatic for-
mation of 2,5-DHBA.
Immunocytochemical Detection of TRPV1, COX-2 and
TNFa in SW982 Synoviocytes
After treatments, the cells on glass coverslips were
washed with phosphate buffered saline (PBS, with 1%
bovine serum albumin (BSA) and 0.9 mM CaCl2 and 0.5
mM MgCl2) and fixed with a mixture of methanol and
4% freshly mixed paraformaldehyde (1:1, v/v) for 10 min
at room temperature. The coverslips were washed and
incubated at room temperature for 30 min with 3% non-
specific species serum. The primary antibody (1:1,000
anti-TRPV1, Alomone, Isreael; 1:1,000 anti-COX-2, BD
Transduction Labs San Diego CA; 1:500 anti-TNFa,
R&D Systems, Minneapolis, MN) was diluted in PBS
with 1.0% normal goat serum (NGS, Sigma Chemical).
The primary antibody was allowed to incubate on the
glass coverslips for 48 h at 4°C, or overnight at room
temperature. The glass coverslips were then washed and
incubated for 30-60 min at room temperature with the
appropriate species secondary IgG antibody with a fluor-
escent ALEXA tag (1:1000 dilution, Alexa Fluor 588
green; Molecular Probes, Inc. Eugene OR). After final
washes, the stained coverslips were inverted onto a dot
of mounting media containing nuclear counterstain
DAPI (VectaShield Hardset, Vector Labs, Burlingame,
CA). Immunocytochemical controls included the
absence of the primary or secondary antibodies, or were
done in the presence of matched serum at the same
dilution. The specificity of the antibodies was confirmed
for TRPV1 by adsorption controls with P-19 N-terminus
peptide provided by Santa Cruz, and for TRPV4 with
peptide 853-871 supplied by Alomone Labs (1:1 w/w, 30
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min). There was no staining in either of the method
controls or the peptide blocked controls. ROS donor
tBOOH (100 mM) stimulated increase in TRPV1 was
greatly reduced by co-incubation with a TRPV1 inhibi-
tor, SB-366791 (30 mM). Stained cells were visualized
with a Nikon FXA microscope equipped with a Cool-
snap digital low light camera and MetaVue image cap-
ture software (Nikon Instruments, Inc. Melville, NY).
Western blot analysis
Low passage SW982 cell cultures were grown in 75 mm
flasks until they reached 70-80% confluency. Proteins
were extracted from control cultures without treatment
and after treatment with H2O2 (1 mM) for 8 h. Western
Blot analysis was performed on whole cell protein frac-
tions extracted from synovial SW982 cells using the
ProteoExtract Subcellular Proteome Extraction kit (Cal-
biochem, Cincinnati, OH). Proteins transferred to mem-
branes were probed with anti-TRPV1 antibody (VR1, P-
19, 1:1000, Santa Cruz, Burlingame, CA) at 4°C over-
night. Amounts of total protein loaded per lane
included: 15 μg for cytosolic and membrane fractions,
10-15 μg for whole cell and 5 μg for rat spinal cord
lysate as a positive control. Western blot analysis was
performed with samples from three experiments.
Power Analysis and Statistical Tests
Statistical analyses for behavioural studies were per-
formed using Prism software. Descriptive statistics for
these data are expressed as mean ± S.D. Behavioral data
were compared with non-parametric repeated measures
analysis of variance using Mann-Whitney U post-hoc
tests unless otherwise specified. For measurements of
ROS concentrations, the overall percent change from
baseline values over time and differences between
groups were compared with a multivariate analysis of
variance (MANOVA). Sigma Plot and Sigma Stat scien-
tific software (SPSS, Chicago, IL) were used for conver-
sion and analysis of acquired data. Data are reported as
means ± SEM. Within subjects, comparisons were made
for baseline, time of injection peak, and time of peak
increase. All statistical comparisons were evaluated at an
alpha level of significance of 0.05.
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